Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study
ME Stein, Z Bernstein, M Tsalic, K Drumea… - American journal of …, 2002 - journals.lww.com
The objective of this study was to investigate the efficacy of our treatment regimen in
metastatic melanoma. Thirty patients entered the study after undergoing a thorough
metastatic workup. Treatment protocol included carmustine (BCNU)(150 mg/m 2 IV, day 1)
every 6 weeks, dacarbazine (DTIC)(220 mg/m 2 IV, days 1–3), and cisplatin (25 mg/m 2 IV,
days 1–3) every 3 weeks, interferon A-2B (6× 10 6 U/m 2 daily sc on days 4–8 and 16–20)
and tamoxifen 20 mg/day for 6 weeks. Among 29 evaluable patients, overall response was …
metastatic melanoma. Thirty patients entered the study after undergoing a thorough
metastatic workup. Treatment protocol included carmustine (BCNU)(150 mg/m 2 IV, day 1)
every 6 weeks, dacarbazine (DTIC)(220 mg/m 2 IV, days 1–3), and cisplatin (25 mg/m 2 IV,
days 1–3) every 3 weeks, interferon A-2B (6× 10 6 U/m 2 daily sc on days 4–8 and 16–20)
and tamoxifen 20 mg/day for 6 weeks. Among 29 evaluable patients, overall response was …
以上显示的是最相近的搜索结果。 查看全部搜索结果